Emerging Prognostic Groups Across the Spectrum of Metastatic Castration-Sensitive Prostate Cancer: Disease Outcomes and Genomics

被引：0
|
作者：
Sutera, P. [1 ]
Van der Eecken, K. [2 ]
Kishan, A. U. [3 ]
Hamid, A. [4 ]
Grist, E. [5 ]
Attard, G. [6 ]
Lotan, T. L. [7 ]
Mendes, A. [1 ]
Sweeney, C. [8 ]
Paller, C. [9 ]
Carducci, M. [9 ]
Ross, A. E. [10 ]
Pienta, K. [11 ]
Feng, F. Y. [12 ]
Eisenberger, M. [9 ]
Antonarakis, E. S. [9 ]
Ost, P. [13 ]
Tran, P. T. [11 ]
Deek, M. P. [9 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Univ Ghent, Ghent, Belgium
[3] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Inst Canc Res Royal Marsden, London, England
[6] Inst Canc Res, London, England
[7] Johns Hopkins Sch Med, Dept Pathol & Oncol, Baltimore, MD USA
[8] Dana Farber Inst, Boston, MA USA
[9] Johns Hopkins Med, Baltimore, MD USA
[10] Northwestern Univ, Chicago, IL 60611 USA
[11] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Med Oncol, Baltimore, MD USA
[12] Univ Calif San Francisco, San Francisco, CA 94143 USA
[13] Ghent Univ Hosp, Dept Radiat Oncol, Ghent, Belgium
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2596
引用
收藏
页码：E294 / E295
页数：2
相关论文
共 50 条
  • [41] Prostate Cancer: Developing Novel Approaches to Castration-Sensitive Disease
    Francini, Edoardo
    Taplin, Mary-Ellen
    CANCER, 2017, 123 (01) : 29 - 42
  • [42] Impact of intensified androgen deprivation therapy (ADTi) in the metastatic castration-sensitive prostate cancer (mCSPC) setting on metastatic castration-resistant prostate cancer (mCRPC) disease characteristics and survival outcomes
    Tripathi, N.
    Gebrael, G.
    Sayegh, N.
    Goel, D.
    Brundage, J.
    Nordblad, B.
    Srivastava, A.
    Dal, E.
    Chehade, C. Hage
    Chigarira, B.
    Thomas, V. Mathew
    Sahu, K.
    Maughan, B. L.
    Agarwal, N.
    Swami, U.
    ANNALS OF ONCOLOGY, 2023, 34 : S973 - S973
  • [43] HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
    Hearn, Jason W. D.
    Sweeney, Christopher J.
    Almassi, Nima
    Reichard, Chad A.
    Reddy, Chandana A.
    Li, Hong
    Hobbs, Brian
    Jarrard, David F.
    Chen, Yu-Hui
    Dreicer, Robert
    Garcia, Jorge A.
    Carducci, Michael A.
    DiPaola, Robert S.
    Sharifi, Nima
    JAMA ONCOLOGY, 2020, 6 (04)
  • [44] RT Improves Outcomes in Some Men With Castration-Sensitive Prostate Cancer
    George, Daniel
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (07) : 367 - 368
  • [45] Letter to the Editor: How We Treat Metastatic Castration-Sensitive Prostate Cancer
    Daungsupawong, Hinpetch
    Wiwanitkit, Viroj
    CANCER CONTROL, 2024, 31
  • [46] Treatment Intensification Patterns and Utilization in Patients with Metastatic Castration-Sensitive Prostate Cancer
    Heath, Elisabeth, I
    Dyson, Gregory E.
    Cackowski, Frank C.
    Hafron, Jason
    Powell, Isaac
    CLINICAL GENITOURINARY CANCER, 2022, 20 (06) : 524 - 532
  • [47] CAN LOCAL RADIOTHERAPY CONVERT METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TO A CASTRATION-SENSITIVE DISEASE? A CASE REPORT
    Terrevazzi, Sara
    Niespolo, Rita Marina
    Colciago, Riccardo Ray
    Villa, Stefano Lorenzo
    Pacifico, Pietro
    Arcangeli, Stefano
    ANTICANCER RESEARCH, 2020, 40 (08) : 4592 - 4592
  • [48] Triplet therapy for metastatic castration-sensitive prostate cancer: Rationale and clinical evidence
    Suzuki, Hiroyoshi
    Akamatsu, Shusuke
    Shiota, Masaki
    Kakiuchi, Haruka
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2025, 32 (03) : 239 - 250
  • [49] A cost-utility analysis of apalutamide for metastatic castration-sensitive prostate cancer
    Parmar, Ambica
    Timilshina, Narhari
    Emmenegger, Urban
    Smoragiewicz, Martin
    Sander, Beate
    Alibhai, Shabbir
    Chan, Kelvin K. W.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (03): : E126 - E131
  • [50] Prognostic Value of Germline DNA Repair Gene Mutations in De Novo Metastatic and Castration-Sensitive Prostate Cancer
    Wei, Yu
    Wu, Junlong
    Gu, Weijie
    Wang, Jun
    Lin, Guowen
    Qin, Xiaojian
    Dai, Bo
    Gan, Hualei
    Ye, Dingwei
    Zhu, Yao
    ONCOLOGIST, 2020, 25 (07): : E1042 - E1050
12345